Basal Forebrain

CervoMed Reports Positive Clinical, Biomarker and MRI Data for Neflamapimod at AAIC 2026

BOSTON, July 14, 2026 CervoMed presented new clinical, plasma biomarker, pharmacokinetic, and imaging analyses at the Alzheimer’s Association International...

By cGxPwire Editor
July 15, 2026

.Clinical

CervoMed Presents Neflamapimod DLB Data at AAIC

BOSTON, July 6, 2026 CervoMed Inc. announced that new clinical findings on its investigational therapy neflamapimod will be presented...

By cGxPwire Editor
July 7, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Basal Forebrain

CervoMed Reports Positive Clinical, Biomarker and MRI Data for Neflamapimod at AAIC 2026

CervoMed Presents Neflamapimod DLB Data at AAIC